BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 23, 2015
View Archived Issues
MaxCyte and Johns Hopkins University form CAR T-cell therapy immuno-oncology collaboration
Read More
TAS-4464, a new agent to treat multiple myeloma
Read More
E-selectin/CXCR4 dual antagonist shows antitumor activity
Read More
AACR and cancer charities fund DNA repair initiative against ovarian cancer
Read More
Astellas and Potenza Therapeutics to collaborate on immuno-oncology therapeutics
Read More
Icon Bioscience's extended-release dexamethasone reduces inflammation after cataract surgery
Read More
GenVec collaborates with LMIV on malaria vaccines
Read More
PPMD funds functional analysis of dystrophin spectrin-like repeats and effects of exon skipping
Read More
Anti-CD22-pyrrolobenzodiazepine ADC shows antitumor activity in vivo
Read More
Mission Therapeutics describes novel UCH-L1 inhibitors tested in vivo
Read More
Tolerability, activity of antibody-drug conjugate SAR-408701 encourage clinical development
Read More
First patient safety and pharmacokinetic data reported for LOXO-101
Read More
Capricor stem cell product given FDA orphan status for Duchenne muscular dystrophy
Read More
Cantrixil named orphan drug by FDA for ovarian cancer
Read More
SRX-1177 designated orphan drug in U.S. for metastatic melanoma
Read More
Ono Pharmaceutical requests squamous NSCLC indication for nivolumab
Read More
Phase I/IIa clinical trial initiated of dual FLT3/MEK inhibitor for hematologic malignancies
Read More
Post-hoc trial analyses enable Kamada to progress with inhaled AAT
Read More
FDA approves filgrastim for myelosuppression in acute radiation injury
Read More
Mnemosyne Pharmaceuticals discloses NR2A antagonists
Read More
Aurigene divulges PD-1 signaling pathway inhibitors
Read More
Trefoil Therapeutics patents modified FGFs
Read More
Canadian scientists describe novel lincRNAs and siRNAs
Read More
Dutrebis approved in E.U. for HIV-1 infection
Read More
Russian scientists present novel protein kinases inhibitors
Read More
OncoMed starts phase II trial of demcizumab in first-line metastatic pancreatic cancer
Read More